A double-blind, multinational, randomized, placebo-controlled trial evaluating aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis (CF), mild lung disease and P. aeruginosa (PA)

✍ Scribed by C. Wainwright; C. Nakamura; D. Geller; A.B. Montgomery

• Book ID: 118642521
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 53 KB
• Volume: 9
• Category: Article
• ISSN: 1569-1993
• DOI: 10.1016/s1569-1993(10)60082-3